Molecular Partners Ag annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Molecular Partners Ag reported −CHF52.0M in free cash flow for fiscal 2025, an increase of CHF8.0M from the previous fiscal year.
View full Molecular Partners Ag company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −CHF52.0M | CHF8.0M | — | — |
| 2024 | 2024-12-31 | −CHF60.0M | −CHF373,000 | — | −1206.30% |
| 2023 | 2023-12-31 | −CHF59.6M | −CHF177.0M | — | −846.55% |
| 2022 | 2022-12-31 | CHF117.4M | CHF209.3M | — | +61.91% |
| 2021 | 2021-12-31 | −CHF91.9M | −CHF61.5M | — | −942.03% |
| 2020 | 2020-12-31 | −CHF30.4M | −CHF28.2M | — | −325.71% |
| 2019 | 2019-12-31 | −CHF2.2M | — | — | −10.89% |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Over the last five reported fiscal years, free cash flow declined from −CHF30.4M to −CHF52.0M, a net decrease of CHF21.5M.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Molecular Partners Ag filings at SEC.gov ↗